ConductScience.org, home

Paper36596352

Artificial intelligence-based multi-omics analysis fuels cancer precision medicine.

He X and 4 others. Semin Cancer Biol, 2023. Cited by 317 papers, by iCite.

Cite this record

ConductScience Library. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. Papers, record 36596352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36596352

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine.
PubMed
Journal
Semin Cancer Biol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
317
iCite
Relative citation ratio, by iCite
31.1
iCite
Revised in PubMed
2023-02-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1He XXiujing
2Liu XXiaowei
3Zuo FFengli
4Shi HHubing
5Jing JJing

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Artificial IntelligenceMajor topic
NeoplasmsMajor topic
Humans
Precision Medicine
Multiomics
Transcriptome

Cited by232

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 317 citations.

PMIDTitleJournalYearIn PapersSource
42984500MR-supported candidate genes and pathway analysis between ischemic stroke and osteoporosis: an integrated multi-omics study.Front Immunol2026https://conductscience.org/library/papers/42984500PubMed
42935868Neurovascular Retinomics for Noninvasive Profiling of Cancer Risk: A Prospective Cohort Study in the UK Biobank.Ophthalmol Sci2026https://conductscience.org/library/papers/42935868PubMed
42923287Research progress and clinical translation prospects of multiple urinary biomarkers in non-invasive diagnosis of urothelial carcinoma.Front Oncol2026https://conductscience.org/library/papers/42923287PubMed
42904056Cytomics-driven insights for investigating host-pathogen interactions.Hlife2026https://conductscience.org/library/papers/42904056PubMed
42898827Gut microbiota in esophageal cancer: mechanisms, clinical implications, and therapeutic potential.Front Microbiol2026https://conductscience.org/library/papers/42898827PubMed
42890802Progress of metabolomics-centric multi-omics research in medicine.IMetaOmics2026https://conductscience.org/library/papers/42890802PubMed
42882898The Molecular Landscape of the Senescence-EMT Interplay: Deciphering Tumour Plasticity Through Molecular Signatures and Multi-Omic Profiling.Cancers (Basel)2026https://conductscience.org/library/papers/42882898PubMed
42824332Transition Toward Multimodal Integration in Cancer Therapy: Biological Rationales, Clinical Efficacy, and Pharmacological Challenges.Cureus2026https://conductscience.org/library/papers/42824332PubMed
42794948Biomimetic Nanocarriers for Glioblastoma Therapy: Translational Advances and Strategic Challenges.Cancers (Basel)2026https://conductscience.org/library/papers/42794948PubMed
42782779Targeting Glycolytic Reprogramming in Gastric Cancer: Navigating the Translational Maze from Mechanism to Clinic.Cells2026https://conductscience.org/library/papers/42782779PubMed
42775263One patient with synchronous multiple primary colon cancers which is easy to miss: a case report.Front Surg2026https://conductscience.org/library/papers/42775263PubMed
42723078Multi-omics characterization of a GPRC5A+ epithelial subpopulation associated with malignant features in colorectal cancer.J Transl Med2026https://conductscience.org/library/papers/42723078PubMed
42699460Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review.Front Pharmacol2026https://conductscience.org/library/papers/42699460PubMed
42656953Multi-omics-driven precision medicine.Imeta2026https://conductscience.org/library/papers/42656953PubMed
42652104AI-Guided Long Non-Coding RNA Target Discovery for Precision Medicine: Integrating GWAS, Multi-Omics, Experimental Validation, and RNA Therapeutics.Biomedicines2026https://conductscience.org/library/papers/42652104PubMed
42643518Editorial: AI-powered integrative multi-omics for precision cancer therapies.Front Cell Dev Biol2026https://conductscience.org/library/papers/42643518PubMed
42619640Multi-omic analyses of the same sample using metabolomics, lipidomics, proteomics, phosphoproteomics, and glycoproteomics.Chem Commun (Camb)2026https://conductscience.org/library/papers/42619640PubMed
42583540Beyond the mutation: integrating radiogenomics, epigenetics, and immune signatures to overcome therapeutic resistance in CNS tumors: a narrative review.Ann Med Surg (Lond)2026https://conductscience.org/library/papers/42583540PubMed
42563687Multi‑omics insights into uveitis: From mechanisms to precision medicine (Review).Int J Mol Med2026https://conductscience.org/library/papers/42563687PubMed
42540689Beyond morphology: imaging the glioblastoma microenvironment in the era of quantitative neuro-oncology.Front Med (Lausanne)2026https://conductscience.org/library/papers/42540689PubMed

See all 232 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36596352

GET https://conductscience.org/api/papers/v1/36596352/cited_by?page=2